C-MET as a Biomarker in Patients with Surgically Resected Non-Small Cell Lung Cancer

被引：0
|
作者：
Tsakonas, G. [1 ]
Hirsch, F. R. [2 ]
Ekman, S. [1 ]
机构：
[1] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden
[2] Univ Colorado, Ctr Canc, Aurora, CO USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
c-Met; non-small cell lung cancer; early stage;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.02-070
引用
收藏
页码：S2124 / S2125
页数：2
相关论文
共 50 条
  • [31] Proteasome Inhibitors Diminish c-Met Expression and Induce Cell Death in Non-Small Cell Lung Cancer Cells
    Li, Yanhui
    Dong, Su
    Tamaskar, Arya
    Wang, Heather
    Zhao, Jing
    Ma, Haichun
    Zhao, Yutong
    ONCOLOGY RESEARCH, 2020, 28 (05) : 497 - 507
  • [32] Confirmation of the role of diabetes in the local recurrence of surgically resected non-small cell lung cancer
    Varlotto, J.
    Medford-Davis, L. N.
    Recht, A.
    Flickinger, J.
    Schaefer, E.
    Shelkey, J.
    Lazar, M.
    Campbell, D.
    Nikolov, M.
    DeCamp, M. M.
    LUNG CANCER, 2012, 75 (03) : 381 - 390
  • [33] Development of a SPECT Tracer to Image c-Met Expression in a Xenograft Model of Non-Small Cell Lung Cancer
    Han, Zhaoguo
    Xiao, Yadi
    Wang, Kai
    Yan, Ji
    Xiao, Zunyu
    Fang, Fang
    Jin, Zhongnan
    Liu, Yang
    Sun, Xilin
    Shen, Baozhong
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (11) : 1686 - 1691
  • [34] Coexpression of c-Met and Notch-1 correlates with poor prognosis in resected non-small-cell lung cancer
    Wang, Ximing
    Song, Na
    Zhang, Ye
    Cai, Ying
    Liu, Yunpeng
    Qu, Xiujuan
    Li, Zhi
    Li, Danni
    Hou, Kezuo
    Kang, Jian
    Hu, Xuejun
    TUMOR BIOLOGY, 2015, 36 (09) : 7053 - 7059
  • [35] Discovery of LAH-1 as potent c-Met inhibitor for the treatment of non-small cell lung cancer
    Sima, Lijie
    Wang, Zhongyuan
    Yu, Ling
    Hou, Youli
    Zhao, Dongsheng
    Luo, Bilan
    Liao, Weike
    Liu, Xinfu
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2024, 39 (01)
  • [36] Surveillance of resected non-small cell lung cancer
    Lopez-Gonzalez, A.
    Ibeas Millan, P.
    Cantos, B.
    Provencio, M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (10) : 721 - 725
  • [37] Surveillance of resected non-small cell lung cancer
    A. López-González
    P. Ibeas Millán
    B. Cantos
    M. Provencio
    Clinical and Translational Oncology, 2012, 14 : 721 - 725
  • [38] Clinical Impact of Histologic Type in Patients with Surgically Resected Stage II and III Non-small Cell Lung Cancer
    Kim, H. R.
    Yun, J. K.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S294 - S295
  • [39] Quantitative severity of pulmonary emphysema as a prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer
    Lee, Seung Jun
    Yoo, Jung Wan
    Ju, Sunmi
    Cho, Yu Ji
    Kim, Jong Duk
    Kim, Sung Hwan
    Jang, In-Seok
    Jeong, Bae Kwon
    Lee, Gyeong-Won
    Jeong, Yi Yeong
    Kim, Ho Cheol
    Bae, Kyungsoo
    Jeon, Kyung Nyeo
    Lee, Jong Deog
    THORACIC CANCER, 2019, 10 (03) : 421 - 427
  • [40] The Clinical Significance of Immune-Nutritional Parameters in Surgically Resected Elderly Patients with Non-Small Cell Lung Cancer
    Shoji, F.
    Miura, N.
    Akamine, T.
    Matsubara, T.
    Kozuma, Y.
    Haratake, N.
    Takamori, S.
    Katsura, M.
    Takada, K.
    Toyokawa, G.
    Takenaka, T.
    Yamazaki, K.
    Okamoto, T.
    Takeo, S.
    Maehara, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2344 - S2344
12345